Related references
Note: Only part of the references are listed.Risk of Mortality Associated with Non-selective Antimuscarinic medications in Older Adults with Dementia: a Retrospective Study
Nandita Kachru et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson's Disease and Comorbid Depression
Farid Chekani et al.
DRUG HEALTHCARE AND PATIENT SAFETY (2020)
2020 Alzheimer's disease facts and figures
[Anonymous]
ALZHEIMERS & DEMENTIA (2020)
Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary
Emily Reeve et al.
MEDICAL JOURNAL OF AUSTRALIA (2019)
First-line treatment of essential hypertension: A real-world analysis across four antihypertensive treatment classes
Manfred Stapff et al.
JOURNAL OF CLINICAL HYPERTENSION (2019)
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment 2019
Deborah J. Lightner et al.
JOURNAL OF UROLOGY (2019)
Antimuscarinic use and discontinuation in an older adult population
Scott Martin Vouri et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2019)
Relationship Between Central Obesity, General Obesity, Overactive Bladder Syndrome and Urinary Incontinence Among Male and Female Patients Seeking Care for Their Lower Urinary Tract Symptoms
H. Henry Lai et al.
UROLOGY (2019)
More on Long-Term Effects of Finasteride on Prostate Cancer Mortality
Manfred P. Stapff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Variation in Cardiovascular Risk Related to Individual Antimuscarinic Drugs Used to Treat Overactive Bladder: A UK Cohort Study
Alejandro Arana et al.
PHARMACOTHERAPY (2018)
Using a Federated Network of Real-World Data to Optimize Clinical Trials Operations
Umit Topaloglu et al.
JCO CLINICAL CANCER INFORMATICS (2018)
Using real world data to assess cardiovascular outcomes of two antidiabetic treatment classes
Manfred Paul Stapff
WORLD JOURNAL OF DIABETES (2018)
The prescribing cascade revisited
Paula A. Rochon et al.
LANCET (2017)
Association of lower urinary tract syndrome with peripheral arterial occlusive disease
Wei-Yu Lin et al.
PLOS ONE (2017)
Evaluation of Overactive Bladder in Male Antidepressant Users: A Prospective Study
Volkan Solmaz et al.
INTERNATIONAL NEUROUROLOGY JOURNAL (2017)
Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis
Scott Martin Vouri et al.
ARCHIVES OF GERONTOLOGY AND GERIATRICS (2017)
The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis
Hisanori Kobayashi et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2016)
USE OF CHOLINESTERASE INHIBITORS INCREASES INITIATION OF URINARY ANTICHOLINERGICS IN PERSONS WITH ALZHEIMER'S DISEASE
Pasi Lampela et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2016)
Antimuscarinics in the Treatment of OAB: Is there a First-Line and a Second-Line Choice?
Apostolos Apostolidis
CURRENT DRUG TARGETS (2015)
Reducing Inappropriate Polypharmacy The Process of Deprescribing
Ian A. Scott et al.
JAMA INTERNAL MEDICINE (2015)
Acetylcholinesterase Inhibitors: Pharmacology and Toxicology
Mirjana B. Colovic et al.
CURRENT NEUROPHARMACOLOGY (2013)
Antimuscarinics for the treatment of neurogenic detrusor overactivity
J. J. Wyndaele
SPINAL CORD (2013)
Rationale for the Use of Anticholinergic Agents in Overactive Bladder With Regard to Central Nervous System and Cardiovascular System Side Effects
Bulent Cetinel et al.
KOREAN JOURNAL OF UROLOGY (2013)
American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults
Donna Fick et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2012)
Treatments for Overactive Bladder: Focus on Pharmacotherapy
Roxana Geoffrion et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2012)
Symptom-based diagnosis of overactive bladder: an overview
Alan Wein
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL (2011)
Prevalence and Predictors of Anticholinergic Medication Use in Elderly Nursing Home Residents with Dementia Analysis of Data from the 2004 National Nursing Home Survey
Satabdi Chatterjee et al.
DRUGS & AGING (2010)
Use of Antipsychotics among Elderly Nursing Home Residents with Dementia in the US An Analysis of National Survey Data
Pravin Kamble et al.
DRUGS & AGING (2009)
HOW TO MANAGE OVERACTIVE BLADDER IN ELDERLY INDIVIDUALS WITH DEMENTIA? A COMBINED USE OF DONEPEZIL, A CENTRAL ACETYLCHOLINESTERASE INHIBITOR, AND PROPIVERINE, A PERIPHERAL MUSCARINE RECEPTOR ANTAGONIST
Ryuji Sakakibara et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2009)
Urinary Incontinence and Overactive Bladder in Patients With Heart Failure
Mary H. Palmer et al.
JOURNAL OF UROLOGY (2009)
Drug therapy - Management of overactive bladder
JG Ouslander
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
DC Suh et al.
DRUGS & AGING (2004)
Cholinesterase inhibitors for the treatment of Alzheimer's disease: Getting on and staying on
GT Grossberg
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2003)
Selective serotonin reuptake inhibitor-induced urinary incontinence
KLL Movig et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2002)
Effect of subchronic administration of metrifonate, rivastigmine and donepezil on brain acetylcholine in aged F344 rats
C Scali et al.
JOURNAL OF NEURAL TRANSMISSION (2002)
Urinary incontinence: an unrecognised adverse effect with donepezil
M Hashimoto et al.
LANCET (2000)